Refine
Has Fulltext
- yes (16)
Is part of the Bibliography
- yes (16)
Document Type
- Journal article (16)
Keywords
- Parkinson’s disease (2)
- Qualitätssicherung (2)
- autoantibodies (2)
- biomarkers (2)
- norepinephrine (2)
- pharmacovigilance (2)
- proteomics (2)
- quality assurance (2)
- substantia nigra pars compacta (2)
- 65-kda isoform (1)
- ADHD (1)
- Biomarkers (1)
- Braak (1)
- Dendritische Zelle (1)
- Disease progression (1)
- Disease-modifying therapies (1)
- Drug development (1)
- GFAP (1)
- Glutamic-acid decarboxylase anxiety (1)
- Immunstimulation (1)
- Kinder und Jugendliche (1)
- Medizin (1)
- Neuroprotection (1)
- Parkinson (1)
- Parkinson's disease (1)
- Pharmakotherapie (1)
- Pharmakovigilanz (1)
- Psychiatrischer Notfall (1)
- Psychopharmakotherapie (1)
- Surrogate endpoints (1)
- TDM (1)
- Therapeutisches Drug Monitoring (1)
- Tourette syndrome (1)
- adult neurogenesis (1)
- adverse drug reactions (1)
- adverse effects (1)
- antibodies (1)
- anxiety (1)
- attention deficit/hyperactivity disorder (ADHD) (1)
- brain development (1)
- catecholamines (1)
- caudate nucleus (1)
- child and adolescent (1)
- dementia with Lewy bodies (1)
- disease progression (1)
- disease-modifying therapies (1)
- disorder (1)
- dopamine (1)
- dopamine transporter (DAT) (1)
- drug development (1)
- drug safety (1)
- fear memory (1)
- granules (1)
- hippocampus (1)
- mental health (1)
- methylphenidate (1)
- mitochondrial pathology (1)
- mitochondrial translation (1)
- neurodegeneration (1)
- neurogenesis (1)
- neuromelanin (1)
- neuromelanin granules (1)
- neurons (1)
- neuroprotection (1)
- noradrenaline (1)
- olfactory bulb neurogenesis (1)
- pharmacotherapy (1)
- pigment (1)
- presynaptic inhibition (1)
- psychiatric emergencies (1)
- psychopharmacotherapy (1)
- psychotropic drugs (1)
- responsivity (1)
- single photon emission computed tomography (SPECT) (1)
- spinal-cord-injury (1)
- stress granules (1)
- striatum (1)
- substantia nigra (1)
- subventricular zone (1)
- surrogate endpoints (1)
- synaptosomes (1)
- tetrahydroisoquinoline derivates (1)
- therapeutic drug monitoring (1)
- tics (1)
- unerwünschte Arzneimittelwirkungen (1)
- ventricular zone (1)
Institute
- Klinik und Poliklinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (12)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (6)
- Neurologische Klinik und Poliklinik (5)
- Institut für Virologie und Immunbiologie (2)
- Klinik und Poliklinik für Nuklearmedizin (1)
- Pathologisches Institut (1)
Tetrahydroisoquinolines (TIQs) such as salsolinol (SAL), norsalsolinol (NSAL) and their methylated derivatives N-methyl-norsalsolinol (NMNSAL) and N-methyl-salsolinol (NMSAL), modulate dopaminergic neurotransmission and metabolism in the central nervous system. Dopaminergic neurotransmission is thought to play an important role in the pathophysiology of chronic tic disorders, such as Tourette syndrome (TS). Therefore, the urinary concentrations of these TIQ derivatives were measured in patients with TS and patients with comorbid attention-deficit/hyperactivity disorder (TS + ADHD) compared with controls. Seventeen patients with TS, 12 with TS and ADHD, and 19 age-matched healthy controls with no medication took part in this study. Free levels of NSAL, NMNSAL, SAL, and NMSAL in urine were measured by a two-phase chromatographic approach. Furthermore, individual TIQ concentrations in TS patients were used in receiver-operating characteristics (ROC) curve analysis to examine the diagnostic value. NSAL concentrations were elevated significantly in TS [434.67 ± 55.4 nmol/l (standard error of mean = S.E.M.), two-way ANOVA, p < 0.0001] and TS + ADHD patients [605.18 ± 170.21 nmol/l (S.E.M.), two-way ANOVA, p < 0.0001] compared with controls [107.02 ± 33.18 nmol/l (S.E.M.), two-way ANOVA, p < 0.0001] and NSAL levels in TS + ADHD patients were elevated significantly in comparison with TS patients (two-way ANOVA, p = 0.017). NSAL demonstrated an AUC of 0.93 ± 0.046 (S.E.M) the highest diagnostic value of all metabolites for the diagnosis of TS. Our results suggest a dopaminergic hyperactivity underlying the pathophysiology of TS and ADHD. In addition, NSAL concentrations in urine may be a potential diagnostic biomarker of TS.